Here is the uncomfortable paradox at the heart of AI-generated research: the better these tools get at writing convincing scientific papers, the harder it becomes to stop them from corrupting science itself.
A University of Zurich postdoctoral researcher named Peter Degen stumbled onto this problem almost by accident. His supervisor noticed that a relatively modest 2017 paper on statistical analysis methods was suddenly being cited hundreds of times — at a rate that made no sense for a niche methodology paper. When Degen went digging, he found a pattern that looked less like scientific progress and more like an assembly line.
The papers citing his supervisor's work were all drawing on the same publicly available dataset — the Global Burden of Disease study — and using it to generate an almost mechanical series of predictions. Stroke risk in adults over 20 years. Testicular cancer in young men. Falls among elderly populations in China. The same formula, swapped out endlessly. A trail of GitHub links eventually led Degen to a company based in Guangzhou that was openly selling tutorials on how to produce a publishable research paper in under two hours using AI writing tools.
This is not a fringe operation. It sits at the intersection of two older problems that academia has never fully solved. The first is the paper mill industry — black-market services that have spent the last decade mass-producing studies and selling authorship credits to researchers who need publications to advance their careers. The second is the chronic understaffing of peer review, a system that already asks experts to evaluate complex research in their spare time, for free.
AI has handed both problems a turbocharger.
What makes the current wave genuinely dangerous is quality — or at least the appearance of it. Earlier AI-generated papers were relatively easy to spot because they made embarrassing factual errors or produced nonsensical citations. The newer generation is subtler. Researchers who examined a batch of AI-assisted papers on headache disorders found them riddled with misrepresentations and methodological errors, but those flaws required real expertise to identify. They were not obviously wrong at first glance.
For journal editors and peer reviewers already stretched thin, that distinction matters enormously. A paper that is flagrantly broken gets rejected quickly. A paper that is plausibly wrong can slip through, get cited, and slowly contaminate the broader literature.
The volume problem alone is staggering. Academic publishing was already struggling to match the supply of submitted papers with enough qualified reviewers before AI arrived. Now that anyone with access to a language model and a public dataset can manufacture a study in an afternoon, the math gets worse every month.
Degen put it bluntly: the peer-review system is already at its limit, and if mass production of papers becomes trivially easy, something is going to break. The optimistic vision of AI accelerating scientific discovery is real and worth taking seriously. But right now, the technology is doing at least as much to erode the infrastructure that makes discovery trustworthy as it is to speed anything up.
STARTUPS
BYD Seeks European Factory Takeovers in Aggressive Global Expansion
BYD is not waiting for Europe to roll out the welcome mat. The Chinese electric vehicle giant is actively negotiating to take over manufacturing facilities from established European automakers — and it is talking to more than one of them.
An executive overseeing BYD's overseas expansion confirmed that the company is in discussions with Stellantis and several other unnamed automakers about acquiring existing factory capacity across the continent. The strategy is straightforward: rather than spending years and billions building new plants from scratch, BYD wants to walk into facilities that already exist, already have workforces, and already have supply chain relationships — and start making cars.
The numbers behind this push are hard to argue with. BYD has now exported more than 100,000 new energy vehicles every single month for six consecutive months. In the first four months of this year alone, the company shipped 456,263 vehicles internationally — a 60 percent jump over the same period last year. That kind of growth does not happen by accident, and it does not sustain itself without serious manufacturing infrastructure outside of China.
Europe is the obvious target for that infrastructure. It is the world's second-largest auto market, it has aggressive electric vehicle adoption mandates on the horizon, and — crucially — it currently has a surplus of factory capacity as legacy automakers struggle to manage their own transitions away from combustion engines.
Stellantis, for instance, has been closing or idling plants as it tries to right-size its operations for a slower-than-expected EV transition. For BYD, that is not a cautionary tale — it is an opportunity. Taking over an underutilized facility means inheriting existing tooling, trained workers, and sometimes supplier relationships, all at a discount compared to greenfield construction.
This approach also carries political advantages that BYD is clearly aware of. European Union tariffs on Chinese-made EVs have been a major headache for the company, with levies designed specifically to offset what regulators argue are unfair subsidies from Beijing. Manufacturing inside Europe — employing European workers, paying European taxes — dramatically changes the political and regulatory calculus. It is much harder to argue that a car built in Germany or Italy is an unfair Chinese import.
BYD has already been pursuing a version of this strategy in other markets. It is building a plant in Hungary and has operations in Brazil and Thailand. The European factory acquisition push is an acceleration of that same logic, applied to markets where political resistance is highest and the prize is largest.
For European automakers, the situation is genuinely complicated. Selling a factory to BYD generates cash they may need, but it also hands a fast-moving competitor a foothold that will be very difficult to dislodge later. The companies in talks with BYD are essentially weighing short-term relief against long-term competition — and some of them appear to be choosing the cash.
Source: TechNode
An executive overseeing BYD's overseas expansion confirmed that the company is in discussions with Stellantis and several other unnamed automakers about acquiring existing factory capacity across the continent. The strategy is straightforward: rather than spending years and billions building new plants from scratch, BYD wants to walk into facilities that already exist, already have workforces, and already have supply chain relationships — and start making cars.
The numbers behind this push are hard to argue with. BYD has now exported more than 100,000 new energy vehicles every single month for six consecutive months. In the first four months of this year alone, the company shipped 456,263 vehicles internationally — a 60 percent jump over the same period last year. That kind of growth does not happen by accident, and it does not sustain itself without serious manufacturing infrastructure outside of China.
Europe is the obvious target for that infrastructure. It is the world's second-largest auto market, it has aggressive electric vehicle adoption mandates on the horizon, and — crucially — it currently has a surplus of factory capacity as legacy automakers struggle to manage their own transitions away from combustion engines.
Stellantis, for instance, has been closing or idling plants as it tries to right-size its operations for a slower-than-expected EV transition. For BYD, that is not a cautionary tale — it is an opportunity. Taking over an underutilized facility means inheriting existing tooling, trained workers, and sometimes supplier relationships, all at a discount compared to greenfield construction.
This approach also carries political advantages that BYD is clearly aware of. European Union tariffs on Chinese-made EVs have been a major headache for the company, with levies designed specifically to offset what regulators argue are unfair subsidies from Beijing. Manufacturing inside Europe — employing European workers, paying European taxes — dramatically changes the political and regulatory calculus. It is much harder to argue that a car built in Germany or Italy is an unfair Chinese import.
BYD has already been pursuing a version of this strategy in other markets. It is building a plant in Hungary and has operations in Brazil and Thailand. The European factory acquisition push is an acceleration of that same logic, applied to markets where political resistance is highest and the prize is largest.
For European automakers, the situation is genuinely complicated. Selling a factory to BYD generates cash they may need, but it also hands a fast-moving competitor a foothold that will be very difficult to dislodge later. The companies in talks with BYD are essentially weighing short-term relief against long-term competition — and some of them appear to be choosing the cash.
Enjoyed this?
Get stories like this delivered every Tuesday — free.